Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression. (2023)
Attributed to:
Defining the underpinnings of Neuropeptide Y (NPY)'s control of hunger and body fat
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.molmet.2022.101665
PubMed Identifier: 36592795
Publication URI: http://europepmc.org/abstract/MED/36592795
Type: Journal Article/Review
Volume: 68
Parent Publication: Molecular metabolism
ISSN: 2212-8778